Watchlist Price Alert

Elicio Therapeutics Inc. (ELTX)

NASDAQ: ELTX · Real-Time Price · USD

5.43

0.02 (0.37%)

At close: May 06, 2025, 11:12 AM

Elicio Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-51.9M	-35.2M	-28.21M	-26.4M	-15.71M	-12.26M	-20.02M
Depreciation & Amortization	1.18M	1.17M	390.32K	251.45K	193.43K	108.37K	2K
Stock-Based Compensation	1.45M	1.18M	579K	617.76K	304.47K	145.08K	n/a
Other Working Capital	7.29M	-80K	-607.35K	842.21K	-2.66M	2.69M	2.46M
Other Non-Cash Items	8.24M	209K	3.6M	667.05K	50.99K	18K	8.29M
Deferred Income Tax	n/a	n/a	947.42K	52.96K	n/a	1.95K	n/a
Change in Working Capital	3.96M	-57K	516.74K	872.43K	-1.54M	2.69M	3.09M
Operating Cash Flow	-37.07M	-32.69M	-22.18M	-23.94M	-16.7M	-9.29M	-8.02M
Capital Expenditures	-87K	-66K	-653.84K	-525.36K	-199.92K	-489.1K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	3K	34K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-84K	-32K	-653.84K	-525.36K	-199.92K	-489.1K	n/a
Debt Repayment	19.73M	10M	n/a	14.03M	n/a	n/a	3.15M
Common Stock Repurchased	n/a	-150K	n/a	n/a	-36K	-375K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	16.96M	21.76M	82K	314.88K	245.59K	6.67M	n/a
Financial Cash Flow	42.32M	38.61M	21.2M	19.39M	25.06M	6.29M	31.74M
Net Cash Flow	5.19M	5.89M	-1.63M	-5.07M	8.16M	-3.49M	23.45M
Free Cash Flow	-37.16M	-32.76M	-22.83M	-24.46M	-16.9M	-9.78M	-8.02M